CureLab Receives $3M from Prominent Biotech Investor Dr. John Ballantyne
Ballantyne is the co-founder and former chief scientific officer of Aldevron, a leading manufacturer of plasmids and other biologicals
November 5, 2022
Novermber 5, 2022
Biotech Internship Opportunity! FDA/USDA liaison
CureLab Oncology and CureLab Veterinary are looking for interns to work with our FDA/USDA team on regulatory activities.
September 14, 2022
September 14, 2022
CureLab Research Results With Cats Published in Animals Journal
Results published by CureLab scientists with the University of Camerino support targeting mammary gland cancers in cats via p62 plasmid
May 19, 2022
May 19, 2022
Review Paper Published by CureLab Veterinary and University of Camerino Shows Additional Opportunities for Use of Elenavet in Treating Domestic Animals
CureLab Veterinary is preparing to start the USDA-CVB process with its patented product and is raising funds to complete the USDA-CVB licensing process in the United States